887P Antitumor activity of the radioenhancer NBTXR3 on injected lesions to estimate overall survival: Exploratory analyses from a phase I in cisplatin-ineligible locally advanced HNSCC patients

Autor: Le Tourneau, C., Takacsi-Nagy, Z., Liem, X., Calugaru, V., Moreno Garcia, V., Calvo, E., Salas, S., Doger de Spéville, B., Dubray-Vautrin, A., Mirabel, X., Badois, N., Chilles, A., Fakhry, N., Wong Hee Kam, S., Debard, A., Serra, A., Finzi, L., Vivar, O.I., Farber, L.A., Lesnik, M.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S568-S569
Databáze: ScienceDirect